Specialties

Dr. Tamara Hannon reviews the current standards of care and recommended medications for treating type 2 diabetes in children and adolescents. She discusses the value of the TODAY study and how we need many more studies like this to improve care for this important and increasing group of type 2 …

Dr. Tamara Hannon talks about the increasing prevalence of type 2 in children and adolescents but reiterates that it is still less common to see type 2 than type 1 diabetes in this age group. She comments that in 2002, when she began her practice, that she saw just a …

Dr. Tamara Hannon talks about how many of her pediatric type 2 diabetes patients are overweight (nearly 100%) and how she determines whether they are type 1 or type 2 (mainly through testing for antibodies). She also discusses how all children are currently at risk for obesity and that around …

Dr. Tamara Hannon talks about the possibility of using one of the most common adult anti-diabetic medications, sulfonylureas, in children. However, she points out that the drugs can only help adults achieve metabolic control in the short-term which concerns her because children and teens with type 2 diabetes definitely need …

Dr. Tamara Hannon talks about the difficult subject of type 2 diabetes complications for adolescents and the challenges they face with the prospect of a longer life with type 2. She also discusses some of the research that has come out that seems to show the disease progressing faster in …

Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …

Treatment of prediabetes and prevention of type 2 diabetes reduces cardiovascular risk…. 

Early studies are showing that the use of vasodilators to lower BP may be related to development of early-stage age-related macular degeneration….

A daughter’s poor health may lead to an increased risk in their parent’s health…. 

An investigational agent, lenvatinib, has shown favorable activity when compared with a placebo with high response rates and delayed disease progression….